PALI Valuation

Palisade Bio Inc

Add to Watchlist

Advanced Chart

1.109

+0.249(28.953%)1D

Overview
Forecast
Valuation
Earnings

PALI Relative Valuation

PALI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PALI is overvalued; if below, it's undervalued.

Historical Valuation

Palisade Bio Inc (PALI) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -0.98. The fair price of Palisade Bio Inc (PALI) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：1.11

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.78

P/B

Median3y

0.49

Median5y

-733.78

-315.37

FCF Yield

Median3y

-254.46

Median5y

-201.28

Competitors Valuation Multiple

The average P/S ratio for PALI's competitors is 0.12, providing a benchmark for relative valuation. Palisade Bio Inc Corp (PALI) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap